Enzo Biochem, Inc. (NYSE: ENZ) reports a Q2 loss of $0.20 compared to a net loss of $0.11 per share ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE